A multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial evaluating the efficacy, safety, and exposure-response relationship of HY-021068 in patients with systemic sclerosis

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 92327931925b6c798efdf2a203a07862bf70d54e
First added on: Apr 19, 2025